Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation

Inik Chang(Yonsei University College of Dentistry), Yuichiro Tanaka(San Francisco VA Medical Center)
Oncotarget
March 27, 2017
Cited by 35


Related Papers